Articles related to COVID-19/CORONAVIRUS
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022
In this cross-sectional study of US adults hospitalized with COVID-19 during January 2022 to April 2022, hospitalization rates from COVID were 10.5 times higher in unvaccinated persons and 2.5 times higher in vaccinated persons with no booster dose, respectively, compared with those who had received a booster dose.
Allergy & Immunology September 20th 2022
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection with Risk of Post–COVID-19 Conditions
This cohort study discovered that depression, anxiety, perceived stress, loneliness, and worry about COVID-19 were prospectively associated with a 1.3- to 1.5-fold increased risk of self-reported post-COVID-19 conditions, as well as an increased risk of daily life impairment related to post-COVID-19 conditions.
Psychiatry September 12th 2022
How Do Telehealth Outcomes Compare to In-Person Care?
Elham Hatef, MD, a clinical informatician at the Johns Hopkins Center for Population Health IT, discussed the findings of her recent study, “Outcomes of in-person and telehealth ambulatory encounters during COVID-19 within a large commercially insured cohort,” in this Q&A with Psych Congress Network.
Psychiatry September 12th 2022
Risk for Myocardial Infarction (MI), Stroke, and Pulmonary Embolism (PE) Following COVID-19 Vaccines in Adults Younger Than 75 Years in France
To assess short-term risk for severe cardiovascular events (excluding myocarditis and pericarditis) after COVID-19 vaccination, adults younger than 75 years hospitalized for PE, acute MI, hemorrhagic stroke, or ischemic stroke (73,325 events) were reviewed in relation to a 1st or 2nd COVID vaccine dose. No association was found between the Pfizer–BioNTech or Moderna vaccine and severe cardiovascular events. The first dose of the Oxford–AstraZeneca vaccine was associated with acute MI and PE in the second week after vaccination. An association with MI in the second week after a single dose of the Janssen vaccine could not be ruled out.
Cardiology September 6th 2022
Somatic Symptom Disorder (SSD) in Patients with Post-COVID-19 Neurological Symptoms: A Preliminary Report from the Somatic Study (Somatic Symptom Disorder Triggered by COVID-19)
This single-center observational study sought to assess the diagnosis of somatic symptom disorder (SSD) in patients with unexplained neurological symptoms occurring in the setting of long COVID. Fifty patients were included in the study. SSD diagnosis based on DSM-5 criteria was positive in 32 (64%) patients. In the remaining 18 patients, SSD was considered possible given the high score on diagnostic scales.
Neurology September 6th 2022
Post-COVID Neurologic, Psychiatric Symptoms May Persist for 2 Years
According to Paul Harrison, FRCPsych, of the University of Oxford in England, and colleagues, health records of nearly 1.3 million people, mostly in the US, revealed that risks of cognitive deficit (brain fog), dementia, psychotic disorders, and epilepsy or seizures were elevated at 2 years for adults who had COVID. Adult COVID patients had an increased risk of anxiety and depression in the first six months, but this risk decreased over time, the researchers reported in Lancet Psychiatry.
Neurology August 22nd 2022